Macclesfield, United Kingdom

Cindy Finnie

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cindy Finnie. Retrieved from https://idiyas.com/inventor/cindy-finnie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cindy Finnie and Pharmaceutical Formulation Innovation.

Introduction

Cindy Finnie is an inventor associated with Macclesfield, Great Britain, and AstraZeneca AB. Her patent work concerns pharmaceutical compositions designed for oral administration.

Latest Patents

The supplied information lists one patent for Cindy Finnie: “Pharmaceutical compositions comprising AZD9291.” The invention describes oral pharmaceutical compositions, including tablets, containing AZD9291 or a pharmaceutically acceptable salt of the compound. The compositions include a specified amount of microcrystalline cellulose and at least one other pharmaceutical diluent. The record lists 1 patent.

Career Highlights

Finnie’s listed patent reflects work on the formulation and delivery of a pharmaceutical compound. The invention focuses on composition ingredients intended for oral administration.

Collaborations

The supplied information names David Wilson and Steven Anthony Raw as coworkers associated with Finnie’s professional context.

Conclusion

Cindy Finnie’s listed invention addresses the formulation of AZD9291 for oral use, highlighting her contribution to pharmaceutical composition development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…